Anton Pak

Dr. Anton Pak

University of Queensland, Brisbane, Queensland, Australia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Frontiers in Public Health
Verified
Journal Article
Open access
APAnton Pak
Anton Pak
Oyelola A AdegboyeOyelola A Adegboye
Oyelola A Adegboye
AAAdeshina I. Adekunle
Adeshina I. Adekunle
KRKazi M. Rahman
Kazi M. Rahman
EMEmma S. McBryde
Emma S. McBryde
DEDamon P. Eisen
Damon P. Eisen
COVID-19 is not only a global pandemic and public health crisis; it has also severely affected the global economy and financial markets. Significant reductions in income, a rise in unemployment, and disruptions in the transportation, service, and manufacturing industries are among the consequences of the disease mitigation measures that have been implemented in many countries. It has become clear that most governments in the world underestimated the risks of rapid COVID-19 spread and were mostly reactive in their crisis response. As disease outbreaks are not likely to disappear in the near future, proactive international actions are required to not only save lives but also protect economic prosperity.

1 January 2021 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
APAnton Pak
Anton Pak
EMEmma McBryde
Emma McBryde
Oyelola A AdegboyeOyelola A Adegboye
Oyelola A Adegboye
Purpose: To examine how public trust mediates the people’s adherence to levels of stringent government health policies and to establish if these effects vary across the political regimes. Methods: This study utilizes data from two large-scale surveys: the global behaviors and perceptions at the onset of COVID-19 pandemic and the Oxford COVID-19 Government Response Tracker (OxCGRT). Linear regression models were used to estimate the effects of public trust and strictness of restriction measures on people’s compliance level. The model accounted for individual and daily variations in country-level stringency of preventative measures. Differences in the dynamics between public trust, the stringent level of government health guidelines and policy compliance were also examined among countries based on political regimes. Results: We find strong evidence of the increase in compliance due to the imposition of stricter government restrictions. The examination of heterogeneous effects suggests that high public trust in government and the perception of its truthfulness double the impact of policy restrictions on public compliance. Among political regimes, higher levels of public trust significantly increase the predicted compliance as stringency level rises in authoritarian and democratic countries. Conclusion: This study highlights the importance of public trust in government and its institutions during public health emergencies such as the COVID-19 pandemic. Our results are relevant and help understand why governments need to address the risks of non-compliance among low trusting individuals to achieve the success of the containment policies.

18 June 2020 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
EMEmma McBryde
Emma McBryde
MMMichael T. Meehan
Michael T. Meehan
Oyelola A AdegboyeOyelola A Adegboye
Oyelola A Adegboye
AAAdeshina I. Adekunle
Adeshina I. Adekunle
JCJamie M. Caldwell
Jamie M. Caldwell
JTJames M. Trauer
James M. Trauer

1 January 2021 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
APAnton Pak
Anton Pak
BGBrenda Gannon
Brenda Gannon
ASAndrew Staib
Andrew Staib

13 June 2022 in Viruses
Verified
Journal Article
Open access
PDF file
Oyelola A AdegboyeOyelola A Adegboye
Oyelola A Adegboye
Maria CastellanosMaria Castellanos
Maria Castellanos
FAFaith Alele
Faith Alele
APAnton Pak
Anton Pak
HEHenry C Ezechukwu
Henry C Ezechukwu
Theophilus I EmetoTheophilus I Emeto
Theophilus I Emeto
Several neglected infectious pathogens, such as the monkeypox virus (MPXV), have re-emerged in the last few decades, becoming a global health burden. Despite the incipient vaccine against MPXV infection, the global incidence of travel-related outbreaks continues to rise. About 472 confirmed cases have been reported in 27 countries as of 31 May 2022, the largest recorded number of cases outside Africa since the disease was discovered in the early 1970s.

1 March 2021 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
Oyelola A AdegboyeOyelola A Adegboye
Oyelola A Adegboye
AAAdeshina I. Adekunle
Adeshina I. Adekunle
APAnton Pak
Anton Pak
EGEzra Gayawan
Ezra Gayawan
DLDenis Hy. Leung
Denis Hy. Leung
DEDamon P. Eisen
Damon P. Eisen